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AcOH: acetic acid: Ar: aryl; BB: building block; Bu: butane; DCE; 1,2-dichloroethane; DCM: 
dichloromethane; DIC: N,N′-diisopropylcarbodiimide; DMF: dimethylformamide; DMAP: 
dimethylaminopyridine, EE: ethyl acetate; ELSD: evaporative light scattering detector; Fmoc: 
fluorenylmethoxycarbonyl; hex: hexane; Lev: levinoyl; NaOMe: sodium methoxide; NIS: N-
iodosuccinimide; NP: normal phase; MeCN: acetonitrile; MeOH: methanol; Ph: phenyl; Py: pyridine; 
RP: reversed phase; rt: room temperature; TBS: tert-butyldimethylsilyl; TfOH: 
trifluoromethanesulfonic acid; THF: tetrahydrofurane; TMSOTf: trimethylsilyl 
trifluoromethanesulfonate; UV: ultra violet. 
 
General Information 
The automated syntheses were performed on a self-built synthesizer developed in the Max Planck 
Institute of Colloids and Interfaces. Linker-functionalized resin L was synthesized according to 
literature procedures1. Resin loading was determined by performing one glycosylation (Module A) 
with BB-1 followed by DBU promoted Fmoc-cleavage and determination of dibenzofulvene 
production by measuring its UV absorbance.2 Advanced intermediates p-tolyl 4,6-O-benzylidene-1-
thio--D-galactopyranosides (BB1-d), p-tolyl 4,6-O-benzylidene-1-thio--D-galactopyranoside (BB1-
d)3, and ethyl 2-O-benzoyl-3,4-O-dibenzyl-6-O-fluorenylcarbonylmethoxy-1-thio-β-D-galacto-
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pyranoside (BB3-a)4 and building block ethyl 2,3,5-tri-O-benzoyl-1-thio-α-L-arabinofuranoside (BB4)5 
were synthesized according to literature procedures. Phosphate BBs (BB-1 to BB-3) were used in the 
automated synthesis as mixtures of -anomers. Solvents and reagents were used as supplied 
without any further purification. Anhydrous solvents were taken from a dry solvent system (JC-Meyer 
Solvent Systems). Column chromatography was carried out using Fluka Kieselgel 60 (230-400 mesh). 
NMR spectra were recorded on a Varian 400-MR (400 MHz), a Varian 600- (600 MHz), or a Bruker 
AVIII 700 (700 MHz) spectrometer using solutions of the respective compound in CDCl3 or D2O. NMR 
chemical shifts () are reported in ppm and coupling constants (J) in Hz. Spectra recorded in CDCl3 
used the solvent residual peak chemical shift as internal standard (CDCl3: 7.26 ppm 
1H, 77.1 ppm 13C). 
Spectra recorded in D2O used an acetic acid peak as internal standard in 
1H NMR (D2O: 2.08 ppm) and 
13C NMR (acetic acid in D2O: 21.03 ppm).
 Yields of final deprotected oligosaccharides were 
determined after removal of residual acetic acid. Optical rotations were measured using a UniPol 
L1000 polarimeter (Schmidt&Haensch) with concentrations expressed as g/100 mL. IR spectra were 
recorded on a Spectrum 100 FTIR spectrophotometer (Perkin-Elmer). High resolution mass spectra 
were obtained using a 6210 ESI-TOF mass spectrometer (Agilent). Analytical HPLC was performed on 
an Agilent 1200 series coupled to a quadrupole ESI LC/MS 6130 using a YMC-Pack DIOL-300-NP 
column (150 x 4.6 mm), a Phenomenex Luna C5 column (250 x 4.6 mm), or a Thermo Scientific 
Hypercarb column (150 x 4.6 mm). Preparative HPLC was performed on an Agilent 1200 series using a 
preparative YMC-Pack-Diol-300-NP (150 x 20 mm) or a semi-preparative Phenomenex Luna C5 
column (250 x 10 mm). 
 
Synthesizer Modules and Conditions  
After placement of the linker-functionalized resin L (16.9 µmol of hydroxyl groups) in the reaction 
vessel the resin was washed with DMF, THF, and DCM. Subsequently the glycosylation (Module A and 
D), deprotection (Module B and C) and capping (Module E) steps were performed. Mixing of the 
components was accomplished by bubbling Argon through the reaction mixture. 
Module A: Glycosylation with Glycosyl Phosphates 
The resin (16.9 µmol of hydroxyl groups) was swollen in DCM (2 mL) and the temperature of the 
reaction vessel was adjusted to -30 °C. Prior to the glycosylation reaction the resin was washed with 
TMSOTf in DCM and DCM. For the glycosylation reaction the DCM was drained and a solution of 
phosphate BB (3.75 equiv. in 1 mL DCM) was delivered to the reaction vessel. After the set 
temperature was reached, the reaction was started by the addition of TMSOTf in DCM (3.75 equiv. in 
1 mL DCM). The glycosylation was performed for 5 min at -35 °C and for 30 min at -20 °C. 
Subsequently the solution was drained and the resin was washed twice with DCM. The whole 
procedure was repeated once to ensure full conversion of all acceptor sites.  
 
Activator solution: 63.5 mM solution of TMSOTf in dry DCM. 
Action Cycles Solvent Reagent 1 Reagent 2 Temperature Incubation Time 
Wash 1 DCM TMSOTf  -30 °C 2 min 
Wash 1 DCM   -30 °C 25 s 




-35 °C 5 min 
-20 °C 30 min 
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Wash 3 DCM   -20 °C 15 s 




-35 °C 5 min 
-20 °C 30 min 
Wash 3 DCM   -20 °C 15 s 
Wash 3 DCM   25 °C 15 s 
 
Module B: Fmoc Deprotection 
The resin was washed with DMF, swollen in 2 mL DMF and the temperature of the reaction vessel 
was adjusted to 25 °C. Prior to the deprotection step the DMF was drained and the resin was washed 
with DMF three times. For Fmoc deprotection 2 mL of a solution of 20% Et3N in DMF was delivered to 
the reaction vessel. After 5 min the solution was drained and the whole procedure was repeated 
another two times. After Fmoc deprotection was complete the resin was washed with DMF, THF and 
DCM.  
 
Deprotection solution: 20% NEt3 in dry DMF. 
Action Cycles Solvent Reagent Temperature Incubation Time 
Wash 3 DMF  25 °C 15 s 
Deprotection 3 DMF NEt3 25 °C 5 min  
Wash 3 DMF  25 °C 15 s 
Wash 3 THF  25 °C 15 s 
Wash 3 DCM  25 °C 15 s 
 
Module C: Lev Deprotection 
The resin was washed with DCM three times and the temperature of the reaction vessel was 
adjusted to 25 °C. For Lev deprotection 1.3 mL DCM remained in the reaction vessel and 0.8 mL of a 
solution of 0.15 M hydrazine acetate in Py/AcOH/H2O (4:1:0.25) was delivered to the reaction vessel. 
After 30 min the reaction solution was drained and the whole procedure was repeated another two 
times. After Lev deprotection was complete the resin was washed with DMF, THF and DCM. 
 
Deprotection solution: 0.15 M hydrazine acetate solution in Py/AcOH/H2O (4:1:0.25). 
Action Cycles Solvent Reagent Temperature Incubation Time 





25°C 30 min 
Wash 3 DMF  25 °C 15 s 
Wash 3 THF  25 °C 15 s 




Module D: Glycosylation with Thioglycosides 
The resin (16.9 µmol of hydroxyl groups) was swollen in DCM (2 mL) and the temperature of the 
reaction vessel was adjusted to -30 °C. Prior to the glycosylation reaction the resin was washed with 
TMSOTf in DCM and DCM. For the glycosylation reaction the DCM was drained and a solution of 
thioglycoside BB (3.75 equiv. in 1 mL DCM) was delivered to the reaction vessel. After the set 
temperature was reached, the reaction was started by the addition of NIS (4.4 equiv.) and TfOH (0.4 
equiv.) in DCM/dioxane (3:1). The glycosylation was performed for 5 min at -40 °C and for 40 min 
at -20 °C. Subsequently the solution was drained and the resin was washed with DCM. The whole 
procedure was repeated once to ensure full conversion of all acceptor sites. Afterwards the resin was 
washed three times with DCM at 25 °C. 
Activator solution: solution of NIS (75 mM) and TfOH (7.5 mM) in anhydrous DCM. 
Action Cycles Solvent Reagent 1 Reagent 2 Temperature Incubation Time 
Wash 1 DCM TMSOTf  -30 °C 2 min 
Wash 1 DCM   -30 °C 15 s 






(7.5 µmol)  
-40 °C 5 min 
-20 °C 40 min 
Wash 1 DCM   -20 °C 15 s 







-40 °C 5 min 
-20 °C 40 min 
Wash 1 DCM   -20 °C 15 s 
Wash 1 DCM   25 °C 15 s 
 
Module E: Benzoylation 
The temperature was adjusted to 25 °C and the resin washed with pyridine (2 mL) three times. For 
benzoylation temperature was set to 40 °C and 2 mL pyridine and 1 mL of a solution containing 0.5 M 
benzoic anhydride and 0.25 M DMAP in DCE were delivered to the reaction vessel. After 30 min the 
reaction solution was drained and the whole procedure was repeated another two times. After 
capping was complete the resin was washed with DCM. 
Benzoylation solution: solution of benzoic anhydride (0.5 M) and DMAP (0.25 M) in anhydrous DCE 
Action Cycles Solvent Reagent Temperature Incubation Time 
Wash 3 pyridine  25 °C 15 s 





40 °C 30 min 
Wash 3 DCM  25 °C 15 s 
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Cleavage from the solid support 
After assembly of the oligosaccharides cleavage from the solid support was accomplished by 
modification of a previously published protocol,1 using the Vapourtec E-Series UV-150 photoreactor 
Flow Chemistry System. The medium pressure metal halide lamp is filtered using the commercially 
available red filter. The resin, suspended in DCM, was loaded into a plastic syringe. The suspension 
was then pumped using a syringe pump (PHD2000, Harvard Aparatus) at 1 mL/min through a 10 mL 
reactor, constructed of 1/8 inch o.d. FEP tubing. The total volume within the photoreactor was 9 mL. 
The temperature of the photoreactor was maintained at 20 °C and the lamp power was 80%. The 
exiting flow was deposited in a 10 mL syringe containing a filter, with a collection flask beneath the 
syringe. 
Synhesis of Building Blocks 




p-Tolyl 3-O-tert-butyldimethylsilyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside (BB1-e) 
 
In 200 mL anhydrous DCM 15.5 g (41.5 mmol) of p-tolyl 4,6-O-benzylidene-1-thio-β-D-galacto-
pyranoside (BB1-d)3 were dissolved. Upon addition of 9.5 g (63.0 mmol) tert-butyl-chloro-
dimethylsilane and 4.8 g (70.5 mmol) imidazole at 0°C under Ar atmosphere a colorless precipitate 
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was formed immediately. The temperature was gradually allowed to reach rt and the reaction 
mixture was stirred at rt overnight. The solution was diluted with DCM and the organic layer was 
washed with sat. aq. NaHCO3-solution twice. The organic layer was dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product was subjected to silica gel column chromatography 
(EE/hex = 1:1) to give the silylether BB1-e (16.3 g, 33.3 mmol, 80% yield) as a colorless solid.  
[α]D
25
 = -11.9 (c 1.8, CHCl3).
 1H NMR (400 MHz, CDCl3) δ = 7.57 – 7.54 (m, 2H, Ar), 7.46 – 7.41 (m, 2H, 
Ar), 7.37 – 7.33 (m, 3H, Ar), 7.03 (d, J = 7.9, 2H, Ar), 5.48 (s, 1H, CHPh), 4.49 (d, J = 9.0, 1H, H-1), 4.38 
(dd, J = 12.3, 1.5, 1H, H-6), 4.05 – 3.99 (m, 2H, H-5, H-6), 3.77 (td, J = 9.0, 1.9, 1H, H-2), 3.72 (dd, J = 
9.1, 3.2, 1H, H-3) 3.50 (d, J = 1.0, 1H, H-4), 2.31 (s, 3H, SPhCH3), 0.87 (s, 9H, TBS ), 0.09 (s, 3H, TBS), 
0.08 (s, 3H, TBS) ppm. 13C NMR{1H} (101 MHz, CDCl3) δ = 138.1, 138.1, 133.7, 129.7, 128.9, 128.1, 
126.4 (12 C, Ar), 101.0 (CHPh), 87.6 (C-1), 76.7 (C-5), 75.6 (C-3), 70.2 (C-4), 69.5 (C-6), 68.1 (C-2), 25.8 
(TBS), 21.3 (SPhCH3), 18.3 (TBS), -4.1 (TBS), -4.5 (TBS) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for 
C26H36NaO5SSi: 511.1950; found 511.1979. IR (neat). νmax = 1240, 1131, 1095, 1040 cm
-1 
1H NMR (400 MHz, CDCl3) of BB1-e: 
 









To 11.8 g (24.2 mmol) of BB1-e in 150 mL anhydrous DCM, 1.48 g (12.0 mmol) of DMAP and 16.4 g 
(72.4 mmol) of benzoic anhydride were added under Ar atmosphere. The solution was cooled to 0 °C 
and 20 mL (145 mmol) of NEt3 were slowly added. After stirring overnight at rt the reaction mixture 
was diluted with DCM followed by washes with sat. aq. NaHCO3-solution and brine. The organic 
phase was subsequently dried over Na2SO4 and concentrated in vacuo. Recrystallization from ethanol 
gave the benzoyl protected galactose BB1-f as colorless crystals in 73% yield (10.5 g, 17.7 mmol). 
1H NMR (400 MHz, CDCl3) δ = 8.06 – 8.02 (m, 2H, Ar), 7.57 (J = 7.4, 1H, Ar), 7.47-7.43 (m, 6H, Ar), 7.39 
– 7.34 (m, 3H, Ar), 7.01 (d, J = 7.9, 2H, Ar), 5.50 (s, 1H, CHPh), 5.44 (t, J = 9.5, 1H, H-2), 4.76 (d, J = 9.9, 
1H, H-1), 4.42 (dd, J = 12.2, 1.2, 1H, H-4), 4.10 (d, J = 3.0, 1H, H-6), 4.05 (dd, J = 12.3, 1.4, 1H, H-6), 
4.01 (dd, J = 9.3, 3.0, 1H, H-3), 3.56 (s, 1H, H-5), 2.30 (s, 3H, SPhCH3), 0.71 (s, 9H, TBS), 0.00 (s, 3H, 
TBS), -0.16 (s, 3H, TBS) ppm. 
The analytical data is in agreement with literature data.6 
 
p-Tolyl 2-O-benzoyl-3-O-tert-butyldimethylsilyl-4-O-benzyl-1-thio-β-D-galactopyranoside (BB1-g) 
 
A 1 M solution of borane in THF (70.7 mL, 70.7 mmol) and TMSOTf (1.97 g, 8.84 mmol) were 
sequentially added to a solution of BB1-f (10.5 g, 17.7 mmol) in anhydrous dichloromethane (50 mL) 
at 0 °C under Ar atmosphere. After stirring for 1.5 h the reaction was quenched by portion-wise 
addition of Et3N/MeOH (1:10) solution until no further gas evolved. The resulting mixture was 
concentrated under reduced pressure and the remains were taken up in DCM and washed with sat. 
aq. NaHCO3-solution and brine. After drying the organic phase over Na2SO4 and removal of the 
solvent in vacuo, 10.1 g (17.0 mmol, 96%) of BB1-g were obtained as colorless foam. 
1H NMR (400 MHz, CDCl3) δ = 8.05 (d, J = 7.2, 2H, Ar), 7.58 (t, J = 7.4, 1H, Ar), 7.46 (t, J = 7.7, 2H, Ar), 
7.40 – 7.29 (m, 7H, Ar), 7.02 (d, J = 8.1, 2H, Ar), 5.63 (t, J = 9.2, 1H, H-2), 5.08 (d, J = 11.6, 1H, CH2Ph), 
4.72 (d, J = 9.7, 1H, H-1), 4.58 (d, J = 11.6, 1H, CH2Ph), 3.96 (d, J = 8.3, 1H, H-3), 3.92 – 3.85 (m, 1H, H-
3), 3.76 (d, J = 2.4, 1H, H-6), 3.61 (ddd, J = 16.8, 14.2, 8.2, 2H, H-6, H-5), 2.29 (s, 3H, SPhCH3), 0.78 (s, 
9H, TBS), 0.10 (s, 3H, TBS), -0.10 (s, 3H, TBS) ppm. 








BB1-g (6 g, 10.1 mmol) and 1.0 g (25.2 mmol) of NaH (60% dispersion in mineral oil) were dissolved in 
50 mL anhydrous THF under Ar atmosphere, resulting in a gray suspension, and 3.6 mL (30.3 mmol) 
of benzylbromide were added drop-wise at 0 °C. The suspension was stirred at rt for 4h. The reaction 
was stopped by the addition of aq. NH4Cl-solution. When no more gas evolved, the organic layer was 
separated and washed with water. The solution was dried over Na2SO4 and the solvent was removed 
in vacuo. The residue was purified by silica gel chromatography (0:1 to 1:9 EE/hex) to afford BB1-h 
(5.08 g, 7.42 mmol) in 73% yield. 
1H NMR (400 MHz, CDCl3) δ = 8.10 – 7.99 (m, 2H, Ar), 7.57 (t, J = 7.4, 1H, Ar), 7.45 (t, J = 7.7, 2H, Ar), 
7.40 – 7.26 (m, 12H, Ar), 6.98 (d, J = 8.1, 2H, Ar), 5.61 (t, J = 9.0, 1H, H-2), 5.08 (d, J = 11.4, 1H, CH2Ph), 
4.71 (d, J = 9.4, 1H, H-1), 4.56 – 4.41 (m, 3H, CH2Ph), 3.96 (d, J = 8.4, 1H, H-3), 3.83 (d, J = 2.4, 1H, H-
4), 3.77 – 3.61 (m, 3H, H-6, H-5), 2.28 (s, 3H, SPhCH3), 0.76 (s, 9H, TBS), 0.09 (s, 3H, TBS), -0.11 (s, 3H, 
TBS) ppm. 
The analytical data is in agreement with literature data.6 
 
p-Tolyl 2-O-benzoyl-4,6-O-dibenzyl-1-thio-β-D-galactopyranoside (BB1-i) 
 
BB1-h (2.52 g, 3.68 mmol) was dissolved in 20 mL anhydrous MeCN under Ar atmosphere at 0 °C. 
When 0.5 mL (4.05 mmol) borontrifluoride etherate were added the solution turned yellow 
immediately. The reaction was stopped after 5 min by neutralization with sat., aq. NaHCO3-solution. 
During the neutralization process a colorless precipitate formed, which was taken up in DCM. The 
organic phase was subsequently washed with brine, dried over Na2SO4 and the solvent was removed 
in vacuo, yielding 1.76 g (3.09 mmol, 84%) of BB1-i as a colorless oil that was used without further 
purification. 
1H NMR (400 MHz, CDCl3) δ = 8.06 (d, J = 7.8 Hz, 2H, Ar), 7.58 (t, J = 7.3 Hz, 2H, Ar), 7.46 (t, J = 7.6 Hz, 
2H, Ar), 7.39 – 7.26 (m, 11H, Ar), 7.03 (d, J = 7.8 Hz, 2H, Ar), 5.22 (t, J = 9.7 Hz, 1H, H-2), 4.74 (d, J = 
9.6 Hz, 3H, H-1, CH2Ph), 4.52 (q, J = 11.6 Hz, 2H, CH2Ph), 3.98 (d, J = 2.6 Hz, 1H, H-4), 3.84 – 3.71 (m, 
4H, H-3, H-5, H-6), 2.49 (d, J = 9.5 Hz, 1H, OH), 2.31 (s, 3H, SPhCH3) ppm. 







Pyridine (1.2 mL, 15.0 mmol) was added to a solution of 2.24 g (3.93 mmol) of BB1-i in 50 mL 
anhydrous DCM. The mixture was stirred for 15 min and 2.59 g (10.0 mmol) FmocCl were added. 
After stirring for additional 6 h at rt the solvent was removed in vacuo and the residue was co-
evaporated with toluene twice. The remaining oil was taken up in DCM, washed with brine twice, 
dried over Na2SO4 and the solvent was removed in vacuo. The remaining oil was taken up and 
crystallization from EtOH yielded BB1-j as colorless crystals in 92% yield (2.86 g, 3.61 mmol). 
[α]D
25
 = +31.8 (c 0.16, CHCl3).
 1H NMR (400 MHz, CDCl3) δ = 8.05 (d, J = 7.4 Hz, 2H, Ar), 7.67 (dd, J = 
7.0, 5.5 Hz, 2H, Ar), 7.54 (t, J = 7.4 Hz, 1H, Ar), 7.47 – 7.28 (m, 18H, Ar), 7.11 (dt, J = 19.3, 7.5 Hz, 3H, 
Ar), 7.02 (d, J = 7.9 Hz, 2H, Ar), 5.71 (t, J = 10.0 Hz, 1H, H-2), 5.06 (dd, J = 9.9, 2.8 Hz, 1H, H-3), 4.83 – 
4.75 (m, 2H, H-1, PhCH2), 4.52-4.43 (m, 3H, PhCH2), 4.29 (dd, J = 10.3, 7.2 Hz, 1H, Fmoc), 4.20 (dd, J = 
10.2, 8.0 Hz, 1H, Fmoc), 4.12 (d, J = 2.1 Hz, 1H, H-4), 4.05 (t, J = 7.4 Hz, 1H, Fmoc), 3.81 (t, J = 6.2 Hz, 
1H, H-5), 3.74 – 3.63 (m, 2H, H-6), 2.30 (s, 3H, SPhCH3) ppm. 
13C NMR{1H} (101 MHz, CDCl3) δ = 165.2, 
154.6 (2C, C=O), 143.3, 142.9, 141.3, 141.2, 138.0, 137.9, 137.9, 133.3, 133.0, 130.0, 129.7, 129.3, 
128.5, 128.5, 128.4, 128.2, 127.9, 127.9, 127.8, 127.2, 127.2, 125.3, 125.0, 120.0 (36C, Ar), 87.2 (C-1), 
79.2 (C-3), 75.1 (PhCH2), 74.0 (C-4), 73.7 (PhCH2), 70.2 (Fmoc), 68.8 (C-2), 68.4 (C-6), 46.5 Fmoc, 21.31 
(SPhCH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for C49H44NaO8S: 815.2654; found 815.2610. IR (neat) 
νmax = 1722, 1276, 1255, 1110 cm
-1. 
 











To a suspension of 5 g dry molecular sieves in 50 mL anhydrous DCM dibutyl phosphate (5 mL, 
25.2 mmol) was added and the mixture was stirred for 1.5 h. Subsequently the molecular sieves were 
allowed to settle for 30 min and the supernatant was added to a solution of BB1-j (10.0 g, 12.6 
mmol) in 100 mL anhydrous DCM, cooled to 0 °C under Ar atmosphere. NIS (3.69 g, 16.4 mmol) and 
TfOH (0.03 mL, 0.34 mmol) were added and the resulting purple reaction mixture was stirred for 1 h. 
The reaction was quenched by addition of sat. aq. NaHCO3-solution and washed with sat. aq. 
Na2S2O3-solution until the color of the organic layer changed from purple to colorless. The layers 
were separated, the organic layer was dried over Na2SO4 and the solvent was removed in vacuo. The 
product was purified by silica gel column chromatography (EE/hex = 1:8 to 1:1) to give the phosphate 
BB1 (9.19 g, 10.2 mmol, 81% yield) as a mixture of anomers ( 4:3) as a highly viscous and 
sticky oil.  
Analytical data for -anomer: 
[α]D
25
 = +22.8 (c 0.23, CHCl3).
 1H NMR (400 MHz, CDCl3) δ = 8.06 (d, J = 7.8, 2H, Ar), 7.66 (t, J = 7.2, 2H, 
Ar), 7.54 (t, J = 7.4, 1H, Ar), 7.49 – 7.39 (m, 4H, Ar), 7.38 – 7.27 (m, 12H, Ar), 7.15 – 7.04 (m, 2H, Ar), 
5.78 (dd, J = 10.4, 8.1, 1H, H-2), 5.41 (t, J = 7.7, 1H, H-1), 5.01 (dd, J = 10.5, 2.9, 1H, H-3), 4.74 (d, J = 
11.3, 1H, PhCH2), 4.54 – 4.43 (m, 3H, PhCH2), 4.29 (ddd, J = 28.4, 10.5, 7.6 Hz, 2H, Fmoc), 4.13 (d, J = 
1.6, 1H, H-4), 4.08 (t, J = 7.2, 1H, Fmoc), 4.05 – 3.95 (m, 2H, OBu), 3.92 (t, J = 6.6, 1H, H-5), 3.78 – 3.61 
(m, 4H, H-6, OBu), 1.61 – 1.54 (m, 2H, OBu), 1.38 – 1.23 (m, 4H, OBu), 1.07 – 0.96 (m, 2H, OBu), 0.87 
(t, J = 7.4, 3H, CH3), 0.67 (t, J = 7.4, 3H, CH3) ppm. 
13C NMR{1H} (101 MHz, CDCl3) δ = 165.1, 154.5 (2C, 
C=O), 143.3, 142.9, 141.3, 141.2, 137.8, 137.7, 133.5, 130.0, 129.3, 128.6, 128.4, 128.4, 128.0, 127.9, 
127.2, 127.2, 125.2, 125.0, 120.1 (23C, Ar), 96.9 (d, J = 4.9 Hz, 1C C-1),77.3 (C-3), 75.4 (PhCH2), 73.9 
(C-5), 73.6 (PhCH2), 73.5 (C-4), 70.2 (Fmoc), 70.0 (C-2), 68.1 (d, J = 6.3 Hz, 1 C OBu), 67.9 (d, J = 6.4 
Hz,1 C, OBu), 67.5 (C-6), 46.6 (Fmoc), 32.1 (d, J = 7.5 Hz, 1 C, OBu), 31.89 (d, J = 7.3 Hz, OBu), 18.6, 
18.3 (2 C, OBu), 13.70, 13.51 (2 C, OBu(CH3)) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for C50H55NaO12P: 




1H NMR (400 MHz, CDCl3) of BB1: 
 










A solution of 6.07 g (10.2 mmol) BB1-g in 100 mL DCM at 0 °C was treated with DMAP (0.75 g 
6.13 mmol), DIC (1.93 g, 15.3 mmol) and levulinic acid (1.7 mL, 16.4 mmol) was added. The solution 
was stirred for 3 h at rt. A white precipitate slowly formed and the solution became pink. After 
complete conversion, the solvent was removed in vacuo and the product was purified by silica gel 
column chromatography (hex/EE = 3:2) to give BB2-a as a colorless foam in 91% yield (6.42 g, 9.27 
mmol) 
[α]D
25 = +23.1 (c 1.4, CHCl3). 
1H NMR (400 MHz,CDCl3) δ = 8.06 – 8.02 (m, 2H, Ar), 7.58 (t, J = 7.4 Hz, 
1H, Ar), 7.45 (t, J = 7.7 Hz, 2H, Ar), 7.38 – 7.26 (m, 7H, Ar), 7.01 (d, J = 7.9 Hz, 2H, Ar), 5.64 – 5.59 (m, 
1H, H-2), 5.10 (d, J = 11.4 Hz, 1H, PhCH2), 4.71 (d, J = 9.6 Hz, 1H, H-1), 4.56 (d, J = 11.4 Hz, 1H, PhCH2), 
4.32 (dd, J = 11.2, 6.9 Hz, 1H, H-6), 4.21 (dd, J = 11.2, 5.5 Hz, 1H, H-6), 3.97 (d, J = 8.8 Hz, 1H, H-3), 
3.81 – 3.73 (m, 2H, H-4, H-5 ), 2.74 (t, J = 6.5 Hz, 2H, Lev(CH2)), 2.53 (t, J = 6.6 Hz, 2H, Lev(CH2)), 2.29 
(s, 3H, SPhCH3), 2.19 (s, 3H, LevCH3), 0.77 (s, 9H, TBS), 0.10 (d, J = 3.5 Hz, 3H, TBS), -0.10 (s, 3H, TBS) 
ppm. 13C NMR (101 MHz, CDCl3){
1H} δ = 206.6, 172.6, 165.3 (3 C, C=O), 138.5, 137.7, 133.1, 132.6, 
130.4, 129.9, 129.5, 128.4, 128.3, 127.9, 127.6 (18 C, Ar), 87.2 (C-1), 76.9, 76.1, 75.7 (C-3), 75.0 
(PhCH2), 71.0 (C-2), 63.6 (C-6), 38.0 (Lev), 29.9 (Lev), 27.9 (Lev), 25.6 (TBS), 21.2 (SPhCH3), 17.9 (TBS), 
-3.92 (TBS), -4.98 (TBS). ESI-HRMS: m/z [M+Na]+ calcd. for C38H48NaO8SSi: 715.2736, found: 715.2652 





1H NMR (400 MHz, CDCl3) of BB2-a: 
 
 
13C NMR (101 MHz, CDCl3) of BB2-a: 
 
 
p-Tolyl 2-O-benzoyl-4-O-dibenzyl-6-O-levulinoyl-1-thio-β-D-galactopyranoside (BB2-b) 
 
BB2-a (6.37 g, 9.27 mmol) was dissolved in 80 mL MeCN, the solution was cooled to 0 °C and 1.3 mL 
(10.1 mmol) of boron trifluoride etherate were added. The solution was stirred at 0 °C for ten min 
and subsequently quenched by the addition of sat. aq. NaHCO3-solution. The product was extracted 
from the aq. solution with DCM and the organic layer was washed with water twice. The organic 
layer was dried over MgSO4. The product BB2-b was obtained in quantitative yields (5.32 g, 
9.27 mmol) as a transparent oil after removal of the solvent in vacuo. 
[α]D
25 = +4.7 (c 1.1, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 8.05 (d, J = 8.1 Hz, 2H, Ar), 7.57 (dd, J = 10.6, 
4.2 Hz, 1H, Ar), 7.45 (t, J = 7.7 Hz, 2H, Ar), 7.37 – 7.28 (m, 7H, Ar), 7.04 (d, J = 7.9 Hz, 2H, Ar), 5.23 (t, J 
= 9.7 Hz, 1H, H-2), 4.82 (d, J = 11.6 Hz, 1H, PhCH2), 4.76 – 4.66 (m, 2H, PhCH2, H-1), 4.35 (dd, J = 11.1, 
6.9 Hz, 1H, H-6), 4.17 (dd, J = 11.2, 6.0 Hz, 1H, H-6), 3.88 (d, J = 2.3 Hz, 1H, H-3), 3.83 (dd, J = 9.5, 3.2 
Hz, 1H, H-4), 3.75 (t, J = 6.4 Hz, 1H, H-5), 2.74 (t, J = 6.5 Hz, 2H, Lev(CH2)), 2.54 (t, J = 6.4 Hz, 2H, 
Lev(CH2)), 2.30 (s, 3H, SPhCH3), 2.17 (s, 3H, LevCH3) ppm. 
13C NMR{1H} (101 MHz, CDCl3) δ = 206.9, 
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172.5, 166.8 (3 C, C=O), 138.1, 137.8, 133.4, 133.1, 130.0, 129.6, 129.6, 128.8, 128.5, 128.5, 127.9, 
127.9 (18 C, Ar), 86.3 (C-1), 76.5 (C-3), 76.1 (C-5), 75.5 (PhCH2), 74.4(C-4), 72.1 (C-2), 63.0 (C-6), 37.9 
(Lev), 29.9 (Lev), 27.8(Lev), 21.2 (SPhCH3) ppm. [M+Na]
+ calcd. for C32H34NaO8S: 601.1872; found 
601.1911. IR (neat) νmax =1723, 1713 1271, 1250 cm
-1. 
1H NMR (400 MHz, CDCl3) of BB2-b: 
 






To a solution of 5.32 g (9.27 mmol) BB2-b in 100 mL DCM and 2.5 mL (30.9 mmol) pyridine 4.83 g 
(18.6 mmol) Fmoc-Cl were added and the solution was stirred at rt for 6 h. Subsequently the mixture 
was evaporated in vacuo and the resulting oil re-dissolved in 50 mL DCM. The organic layer was 
washed with brine three times, dried over Na2SO4, filtered and the solvent was removed in vacuo. 
Recrystallization from ethanol gave the pure product BB2-c in 75% yield (5.60 g, 6.99 mmol) as a 
colorless solid. 
[α]D
25 = +35.7 (c 1.1, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 8.08 – 8.03 (m, 2H, Ar), 7.69 (dd, J = 7.5, 4.2 
Hz, 2H, Ar), 7.56 (t, J = 7.4 Hz, 1H, Ar), 7.49 – 7.29 (m, 13H, Ar), 7.20 – 7.03 (m, 4H, Ar), 5.72 (t, J = 
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10.0 Hz, 1H, H-2), 5.07 (dd, J = 10.0, 2.8 Hz, 1H, H-3), 4.83 (d, J = 11.5 Hz, 1H, PhCH2), 4.80 (d, J = 10.0 
Hz, 1H, H-1), 4.53 (d, J = 11.4 Hz, 1H, PhCH2), 4.37 – 4.29 (m, 2H, H-6, Fmoc), 4.27 – 4.14 (m, 2H, H-6, 
Fmoc), 4.07 (t, J = 7.5 Hz, 1H, Fmoc), 4.04 (d, J = 2.4 Hz, 1H, H-4), 3.81 (t, J = 6.4 Hz, 1H, H-5), 2.74 (t, J 
= 6.1 Hz, 2H, Lev(CH2)), 2.53 (t, J = 6.5 Hz, 2H, Lev(CH2)), 2.31 (s, 3H, SPhCH3), 2.18 (s, 3H, Lev(CH3)). 
13C NMR{1H} (101 MHz, CDCl3) δ = 206.5, 172.4, 165.1, 154.5 (4 C, C=O), 143.3, 142.8, 141.3, 141.2, 
138.2, 137.5, 133.4, 133.0, 130.0, 129.6, 129.6, 129.1, 129.1, 128.5, 128.5, 128.4, 128.0, 127.9, 127.2, 
127.2, 125.2, 125.0, 120.1 (26 C, Ar), 87.1 (C-1), 79.1 (C-3), 75.9 (C-5), 75.0 (PhCH3), 73.5 (C-4), 70.3 
(Fmoc), 68.6 (C-2), 62.7 (C-6), 46.5 (Fmoc), 37.9 (Lev), 29.9 (Lev), 27.8 (Lev), 21.3 (SPhCH3) ppm. 
[M+Na]+ calcd. for C47H44NaO10S: 823.2552, found: 823.2558 IR (neat) νmax = 1742, 1723, 1273, 
1249 cm-1. 
1H NMR (400 MHz, CDCl3) of BB2-c: 
 








To a suspension of 1 g dry molecular sieves in 20 mL anhydrous DCM was added dibutyl phosphate 
(1.0 mL, 5.01 mmol) and the mixture was stirred for 1.5 h. Subsequently the molecular sieves were 
allowed to settle for 30 min, the supernatant was added to a solution of BB2-c (1.85 g, 2.50 mmol) in 
50 mL anhydrous DCM and cooled to 0 °C under Ar atmosphere. NIS (0.73 g, 3.26 mmol) and TfOH 
(0.07 mL, 0.79 mmol) were added and the purple reaction mixture was stirred for 1 h. The reaction 
was quenched by addition of sat. aq. NaHCO3-solution and washed with sat. aq. Na2S2O3-solution 
until the color of the organic layer changed from purple to colorless. The layers were separated, the 
organic layer was dried over Na2SO4 and the solvent removed in vacuo. The product was purified by 
silica gel column chromatograph (EE/hex = 1:8 to 1:1) to give the phosphate BB2 (2.04 g, 2.30 mmol, 
92% yield) as a mixture of anomers ( as a highly viscous and sticky oil. 
Analytical data for -anomer: 
[α]D
25
 = +28.8 (c 0.5, CHCl3) 
1H NMR (400 MHz, CCDl3) δ = 8.10 – 8.02 (m, 2H, Ar), 7.70 – 7.65 (m, 2H, 
Ar), 7.55 (t, J = 7.4 Hz, 1H, Ar), 7.48 (d, J = 7.5 Hz, 1H, Ar), 7.45 – 7.40 (m, 1H, Ar), 7.39 – 7.28 (m, 6H, 
Ar), 7.16 – 7.06 (m, 2H, Ar), 5.81 (dd, J = 10.5, 8.0 Hz, 1H, H-2), 5.42 (t, J = 7.7 Hz, 1H, H-1), 5.02 (dd, J 
= 10.5, 2.9 Hz, 1H, H-3), 4.80 (d, J = 11.2 Hz, 1H, PhCH2), 4.52 (d, J = 11.2 Hz, 1H, PhCH2), 4.40 – 4.18 
(m, 4H, H-6, Fmoc), 4.15 – 3.97 (m, 5H, H-4, Fmoc, OBu), 3.91 (t, J = 6.4 Hz, 1H, H-5), 3.71 (ddq, J = 
27.5, 9.8, 6.7 Hz, 2H, OBu), 2.75 (t, J = 6.5 Hz, 2H, Lev), 2.52 (t, J = 6.5 Hz, 2H, Lev), 2.19 (s, 3H, 
CH3(Lev)), 1.65 – 1.57 (m, 2H, OBu), 1.42 – 1.21 (m, 4H, OBu ), 1.02 (dq, J = 14.7, 7.4 Hz, 2H, OBu), 
0.90 (t, J = 7.4 Hz, 3H, CH3(OBu)), 0.68 (t, J = 7.4 Hz, 3H, CH3(OBu)). 
13C NMR{1H} (101 MHz, CDCl3) δ 
206.4, 172.3, 165.1, 154.4 (4C, C=O), 143.2, 142.8, 141.3, 141.2, 137.2, 133.5, 130.0, 129.2, 128.6, 
128.6, 128.2, 127.9, 127.2, 127.1, 125.2, 125.0, 120.1 (18 C, Ar), 96.8 (d, J = 5.0 Hz), 77.4 (C-3), 75.4 
(PhCH2), 73.1 (C-4), 72.9 (C-5), 70.3 (Fmoc), 69.8 (C-2), 68.1 (d, J = 6.3 Hz, 1C OBu), 68.0 (d, J = 6.3 Hz, 
OBu), 62.2 (C-6), 46.5 (Fmoc), 37.9 (Lev), 32.1 (d, J = 7.5 Hz, 1C, OBu), 31.8 (d, J = 7.4 Hz, 1C, OBu) 
29.9 (Lev), 27.8 (Lev), 18.6, 18.3, 13.6, 13.4 (4C, OBu) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C48H55O14NaP: 909.3227, found: 909.3265. IR (neat) νmax = 1738, 1272, 1250, 1028 cm
-1. 





13C NMR (101 MHz, CDCl3) of BB2: 
 
 






To a suspension of 1 g dry molecular sieves in 50 mL anhydrous DCM was added dibutyl phosphate 
(0.6 mL, 3.0 mmol) and the mixture was stirred for 1.5 h. Subsequently the molecular sieves were 
allowed to settle for 30 min, the supernatant was added to a solution of ethyl 2-O-benzoyl-3-O-
fluorenylcarbonylmethoxy-4,6-O-dibenzyl-1-thio-β-D-galactopyranoside (0.98g, 1.38 mmol) in 100 mL 
anhydrous DCM and cooled to 0 °C under Ar atmosphere. NIS (0.41 g, 1.80 mmol) and TfOH (0.04 mL, 
0.45 mmol) were added and the purple reaction mixture was stirred for 1 h. The reaction was 
quenched by addition of sat. aq. NaHCO3-solution and washed with sat. aq. Na2S2O3-solution until the 
color of the organic layer changed from purple to colorless. The layers were separated, the organic 
layer was dried over Na2SO4 and the solvent removed in vacuo. The product was purified by silica gel 
column chromatography (EE/hex = 1:8 to 1:1) to give the phosphate BB3 (0.98 g, 1.11 mmol, 80% 
yield) as a mixture of anomers ( as a highly viscous and sticky oil.  
Characterization for -anomer: 
1H NMR (400 MHz, CDCl3) δ = 8.05 (d, J = 7.5 Hz, 2H, Ar), 7.78 (d, J = 7.5 Hz, 2H, Ar), 7.63 – 7.55 (m, 
3H, Ar), 7.43 (dt, J = 10.8, 7.6 Hz, 4H, Ar), 7.37 – 7.23 (m, 12H, Ar), 5.94 (dd, J = 6.7, 3.5 Hz, 1H, H-1), 
5.66 (dt, J = 10.4, 3.2 Hz, 1H, H-2), 5.02 (d, J = 11.4 Hz, 1H, PhCH2), 4.74 (s, 2H, PhCH2), 4.64 (d, J = 
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11.4 Hz, 1H, PhCH2), 4.41 (m, 2H, Fmoc, H-5), 4.33 – 4.26 (m, 2H, Fmoc, H-6), 4.25 – 4.19 (m, 2H, H-6, 
Fmoc), 4.16 (dd, J = 10.4, 2.4 Hz, 1H, H-3), 4.06 – 3.95 (m, 3H, H-4, OBu), 3.94 – 3.75 (m, 2H, OBu), 
1.58 – 1.48 (m, 2H, OBu), 1.38 – 1.23 (m, 4H, OBu), 1.14 (dq, J = 15.1, 7.4 Hz, 2H, OBu), 0.84 (t, J = 7.4 
Hz, 3H, OBu), 0.74 (t, J = 7.4 Hz, 3H, OBu) ppm. 13C NMR{1H} (101 MHz, CDCl3) δ = 165.6, 154.7 (2 C, 
C=O), 143.1, 141.2, 137.6, 137.6, 133.2, 129.8, 129.5, 128.4, 128.4, 128.3, 128.3, 127.9, 127.8, 127.6, 
127.1, 125.0, 120.0 (26 C, Ar), 94.8 (d, J = 6.4 Hz, C-1), 75.7 (C-5), 74.8 (PhCH3), 73.6 (C-4), 72.9 
(PhCH2), 70.3 (Fmoc), 70.3 (C-2), 69.9 (C-5), 67.75 (d, J = 5.6 Hz, OBu), 67.69 (d, J = 5.7 Hz, OBu), 66.4 
(C-6), 46.6 (Fmoc), 32.07 (d, J = 7.3 Hz, OBu), 31.89 (d, J = 6.8 Hz, OBu), 18.5 (OBu), 18.3 (OBu), 13.5 
(OBu), 13.4 (OBu) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C50H55NaO12P: 901.3328, found: 901.3199. 
IR (neat) νmax = 1743, 1724, 1251, 1027 cm
-1. 
1H NMR (400 MHz, CDCl3) of BB3: 
 










Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows:  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected trisaccharide 1. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected trisaccharide 1 (ELSD trace): 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected trisaccharide 1 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 0.5 mL) was 
added. The reaction mixture was stirred overnight and subsequently neutralized by addition of 
prewashed Amberlite IR-120 resin. The resin was filtered off and the solvents were removed in 
vacuo. The crude product was purified by reversed phase HPLC using a semi-preparative C5 column 
affording the semi-protected trisaccharide 1. 
Crude RP-HPLC of the semi-protected trisaccharide 1 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected trisaccharide 1 (1.0 mg, 1.76 µmol, 11% over 9 steps, 
based on resin loading). 
1H NMR (600 MHz, D2O) δ = 4.84 (d, J = 7.7 Hz, 1H), 4.79 (d, J = 7.6 Hz, 1H), 4.62 (d, J = 8.0 Hz, 1H), 
4.37 (t, J = 3.0 Hz, 2H), 4.14 – 4.08 (m, 2H), 4.03 – 3.82 (m, 15H), 3.80 – 3.76 (m, 1H), 3.17 (t, J = 7.5 
Hz, 2H), 1.90 – 1.80 (m, 4H), 1.68 – 1.59 (m, 2H) ppm.13C NMR{1H} (151 MHz, D2O) δ = 102.1, 101.8, 
100.1, 80.2, 79.8, 72.9, 72.5, 72.5, 70.3, 68.8, 68.0, 67.7, 67.7, 66.3, 66.3, 66.1, 58.7, 58.7, 37.2, 25.9, 




RP-HPLC of the deprotected trisaccharide 1 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 
of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O in MeCN (10 min, flow rate 0.7 
mL/min). 
1H NMR (600 MHz, D2O) of trisaccharide 1: 
 












Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
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Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected tetrasaccharide 2. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 2 (ELSD trace): 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 






The protected tetrasaccharide 2 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 0.5 mL) 
was added. The reaction mixture was stirred overnight and subsequently neutralized by addition of 
prewashed Amberlite IR-120 resin. The resin was filtered off and the solvents were removed in 





Crude RP-HPLC of the semi-protected tetrasaccharide 2 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 5 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected tetragalactoside 2 (1.3 mg, 1.73 µmol, 10% over 11 
steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 4.86 – 4.83 (m, 2H), 4.79 (d, J = 7.6 Hz, 1H), 4.62 (d, J = 8.0 Hz, 1H), 4.37 
(t, J = 3.1 Hz, 3H), 4.15 – 4.08 (m, 2H), 4.04 – 3.82 (m, 20H), 3.78 (dd, J = 9.9, 7.7 Hz, 1H), 3.19 – 3.15 
(m, 2H), 1.90 – 1.82 (m, 4H), 1.67 – 1.60 (m, 2H) ppm. 13C NMR{1H} (151 MHz, D2O) δ = 102.05, 
101.77, 101.73, 100.14, 80.18, 79.81, 79.75, 72.84, 72.53, 72.48, 70.29, 68.80, 68.00, 67.99, 67.72, 
67.65, 66.33, 66.25, 66.16, 66.10, 58.73, 58.68, 37.16, 25.94, 24.33, 19.88 ppm. ESI-HRMS: m/z 
[M+H]+ calcd. for C29H54NO21: 752.3188, found: 752. 3331 
RP-HPLC of the deprotected tetrasaccharide 2 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 






1H NMR (600 MHz, D2O) of tetrasaccharide 2: 
 












Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
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Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected trisaccharide 3. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected trisaccharide 3 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected trisaccharide 3 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 0.5 mL) was 
added. The reaction mixture was stirred overnight and subsequently neutralized by addition of 
prewashed Amberlite IR-120 resin. The resin was filtered off and the solvents were removed in 
vacuo. The crude product was purified by reversed phase HPLC using a semi-preparative C5 column 




Crude RP-HPLC of semi-protected trisaccharide 3 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected trisaccharide 3 (4.0 mg, 6.72 µmol, 39% over 9 steps, 
based on resin loading). 
1H NMR (700 MHz, D2O) δ = 4.64 (d, J = 7.9 Hz, 1H), 4.62 (d, J = 7.8 Hz, 1H), 4.58 (d, J = 7.9 Hz, 1H), 
4.23 – 4.21 (m, 2H), 4.15 – 4.05 (m, 8H), 3.98 – 3.91 (m, 2H), 3.88 – 3.81 (m, 5H), 3.72 – 3.66 (m, 3H), 
3.18 (t, J = 7.3 Hz, 2H), 1.89 – 1.82 (m, 4H), 1.65 – 1.60 (m, 2H) ppm. 13C NMR{1H} (176 MHz, D2O) δ 
= 101.1, 101.1, 100.5, 72.9, 71.5, 70.5, 70.4, 70.4, 68.5, 68.5, 67.9, 67.0, 66.9, 66.4, 66.4, 58.8, 37.1, 
25.9, 24.2, 19.8 ppm. HRMS: m/z [M+H]+ calcd. for C23H43NO16: 590.2660, found: 590.2710 
RP-HPLC of deprotected trigalactoside 3 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 




1H NMR (700 MHz, D2O) of trigalactoside 3: 
 













Linker functionalized resin L (43 mg, 13.7 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 5 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
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Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 5 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 5 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 5 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected tetrasaccharide 4. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 4 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected, branched tetrasaccharide 4 was dissolved in 5 mL THF and 0.5 mL of 0.5 M NaOMe 
was added. The solution was stirred overnight at rt. The reaction mixture was neutralized using 
prewashed Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. 




Crude RP-HPLC of semi-protected trisaccharide 4 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected tetrasaccharide 4 (1.5 mg, 2.00 µmol, 15% over 11 steps, 
based on resin loading). 
1H NMR (600 MHz, D2O) δ = 4.79 (d, J = 7.8 Hz, 1H), 4.72 (d, J = 7.6 Hz, 1H), 4.57 (d, J = 8.0 Hz, 1H), 
4.54 (d, J = 7.9 Hz, 1H), 4.34 (dd, J = 7.2, 3.2 Hz, 2H), 4.18 – 4.12 (m, 1H), 4.09 – 3.98 (m, 5H), 3.97 – 
3.92 (m, 2H), 3.92 – 3.70 (m, 15H), 3.62 (dd, J = 9.8, 8.0 Hz, 1H), 3.12 (t, J = 7.5 Hz, 2H), 1.80 (tt, J = 
14.0, 7.2 Hz, 4H), 1.61 – 1.55 (m, 2H) ppm. 13C NMR{1H} (151 MHz, D2O) δ = 102.9, 102.5, 102.1, 
101.0, 81.0, 80.6, 73.7, 73.7, 73.4, 72.0, 71.3, 71.1, 69.6, 69.4, 68.8, 68.5, 68.5, 67.8, 67.2, 67.2, 67.1, 
67.0, 59.6, 59.6, 59.5, 38.0, 26.8, 25.0, 20.7 ppm. HRMS: m/z [M+Na]+ calcd. for C29H53NNaO21: 
774.3007, found 774. 3030 
RP-HPLC of deprotected tetrasaccharide 4 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 





1H NMR (600 MHz, D2O) of tetrasaccharide 4: 
 
13C NMR (151 MHz, D2O) of tetrasaccharide 4: 
 









Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected pentasaccharide 5. The crude product was purified by normal phase HPLC using a 




Crude NP-HC of protected pentasaccharide 5 (ELSD trace):  
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected, branched pentasaccharide 5 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was 
added. The solution was stirred overnight at rt. The reaction mixture was neutralized using 
prewashed Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. 




Crude RP-HPLC of semi-protected pentasaccharide 5 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected pentasaccharide 5 (1.6 mg, 1.73 µmol, 10% over 13 
steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 4.82 (d, J = 7.8 Hz, 1H), 4.75 (d, J = 7.7 Hz, 1H), 4.61 – 4.56 (m, 3H), 4.37 
(dd, J = 8.1, 2.9 Hz, 2H), 4.19 – 4.14 (m, 2H), 4.11 – 3.98 (m, 9H), 3.97 – 3.73 (m, 17H), 3.69 – 3.63 (m, 
2H), 3.14 (t, J = 7.5 Hz, 2H), 1.82 (tt, J = 14.3, 7.4 Hz, 4H), 1.63 – 1.56 (m, 2H) ppm. 13C NMR{1H} (176 
MHz, D2O) δ = 102.0, 101.5, 101.2, 101.1, 100.0, 80.1, 79.7, 72.8, 72.8, 72.5, 71.4, 70.9, 70.4, 70.3, 
70.2, 68.7, 68.4, 68.4, 67.9, 67.6, 67.5, 67.1, 67.0, 66.3, 66.1, 66.0, 58.7, 58.7, 58.6, 37.0, 25.8, 24.1, 
19.8 ppm. HRMS: m/z [M+H]+ calcd. for C35H64NO26: 914.3716, found: 914.3783 
RP-HPLC of the deprotected pentasaccharide 5 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 
of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O in MeCN (10 min, flow 




1H NMR (700 MHz, D2O) of pentagalactoside 5: 
 
13C NMR (176 MHz, D2O) of pentagalactoside 5: 
 










Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected hexasaccharide 6. The crude product was purified by normal phase HPLC using a 




Crude NP-HPLC of protected hexasaccharide 6 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 






The protected, branched hexasaccharide 6 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was 
added. The solution was stirred overnight at rt. The reaction mixture was neutralized using 
prewashed Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. 





Crude RP-HPLC of the semi-protected hexasaccharide 6 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% 
of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected hexasaccharide 6 (0.9 mg, 0.84 µmol, 7% over 15 steps, 
based on resin loading). 
1H NMR (700 MHz, D2O) δ = 4.86 (d, J = 7.9 Hz, 1H), 4.79 (d, J = 7.7 Hz, 1H), 4.66 – 4.60 (m, 4H), 4.43 – 
4.39 (m, 2H), 4.24 – 4.18 (m, 3H), 4.15 – 4.06 (m, 11H), 4.04 (dd, J = 9.9, 3.3 Hz, 1H), 4.01 – 3.81 (m, 
17H), 3.78 (dd, J = 9.8, 7.7 Hz, 1H), 3.73 – 3.67 (m, 3H), 3.19 – 3.16 (m, 2H), 1.90 – 1.83 (m, 4H), 1.66 
– 1.61 (m, 2H) ppm. 13C NMR{1H} (176 MHz, D2O) δ = 102.1, 101.6, 101.2 (3 C), 100.1, 80.2, 79.7, 72.9, 
72.8, 72.5, 71.5, 71.4, 71.0, 70.5, 70.3, 70.3, 68.8, 68.5, 67.9, 67.7, 67.6, 67.2, 67.1, 67.0, 66.4, 66.2, 
66.1, 58.8, 58.7, 37.1, 25.9, 24.2, 19.8 ppm. HRMS: m/z [M+Na]+ calcd. for C41H73NNaO31: 1098.4064 
found: 1098.4163 
RP-HPLC of deprotected hexasaccharide 6 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O in 
MeCN (10 min, flow rate 0.7 mL/min). 
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1H NMR (700 MHz, D2O) of hexasaccharide 6: 
 

















Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected hexasaccharide 7. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected hexasaccharide 7 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 








The protected branched hexasaccharide 7 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was 
added. The solution was stirred overnight at rt. The reaction mixture was neutralized using 
prewashed Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. 
The semi-protected product was purified by semi-preparative RP-HPLC (C5 column). 
Crude RP-HPLC of the semi-protected hexasaccharide 7 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected hexasaccharide 7 (0.9 mg, 0.84 µmol, 5% over 15 steps, 
based on resin loading). 
1H NMR (600 MHz, D2O) δ = 4.87 – 4.84 (m, 2H), 4.79 (d, J = 7.6 Hz, 1H), 4.63 – 4.60 (m, 3H), 4.42 – 
4.35 (m, 3H), 4.23 – 4.18 (m, 2H), 4.13 – 4.03 (m, 8H), 4.02 – 3.76 (m, 23H), 3.73 – 3.66 (m, 2H), 3.20 
– 3.16 (m, 2H), 1.90 – 1.82 (m, 4H), 1.67 – 1.61 (m, 2H) ppm. 13C NMR{1H} (151 MHz, D2O) δ = 102.0, 
101.7, 101.6, 101.2, 101.2, 100.1, 80.2, 79.8, 79.7, 72.9, 72.8, 72.5, 72.4, 71.4, 71.0, 70.5, 70.4, 70.3, 
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68.8, 68.5, 68.5, 67.9, 67.7, 67.6, 67.2, 67.0, 66.4, 66.3, 66.2, 66.1, 66.1, 58.8, 58.7, 58.7, 37.1, 25.9, 
24.1, 19.8 ppm. HRMS: m/z [M+Na]+ calcd. for C41H73NNaO31: 1098. 4064, found: 1098.4173 
RP-HPLC of the deprotected hexasaccharide 7 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 
of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O in MeCN (10 min, 0.7 mL/min). 
1H NMR (600 MHz, D2O) of hexasaccharide 7: 
 












Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
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Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected tetrasaccharide 8. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 8 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected tetrasaccharide 8 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was added. 
The solution was stirred overnight at rt. The reaction mixture was neutralized using prewashed 
Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. The semi-




Crude RP-HPLC of the semi-protected tetrasaccharide 8 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected tetrasaccharide 8 (2.0 mg, 2.81 µmol, 17% over 10 steps, 
based on resin loading). 
1H NMR (700 MHz, D2O) δ =  6.13 (s, 1H), 5.59 – 5.54 (m, 2H), 5.34 (d, J = 8.0 Hz, 1H), 5.11 – 5.08 (m, 
3H), 5.03 – 4.99 (m, 2H), 4.86 – 4.82 (m, 2H), 4.75 – 4.70 (m, 3H), 4.69 – 4.55 (m, 15H), 3.90 (t, J = 7.5 
Hz, 2H), 2.62 – 2.54 (m, 4H), 2.38 – 2.33 (m, 2H) ppm. 13C NMR{1H} (176 MHz, D2O) δ = 107.0, 101.8, 
101.8, 100.1, 81.6, 80.2, 79.8, 79.0, 77.8, 74.3, 72.7, 72.5, 72.5, 68.0, 67.7, 67.6, 66.2, 66.1, 59.0, 
58.6, 37.1, 25.9, 24.1, 19.8 ppm. HRMS: m/z [M+H]+ calcd. for C28H51NO20: 722.3082, found: 
722.3036. 
 
RP-HPLC of the deprotected tetrasaccharide 8 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 
of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O in MeCN (10 min, flow 




1H NMR (700 MHz, D2O) of tetrasaccharide 8: 
 















Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (3 cycles)  
Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected tetrasaccharide 9. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 9 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 






The protected tetrasaccharide 9 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was added. 
The solution was stirred overnight at rt. The reaction mixture was neutralized using prewashed 
Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. The semi-
protected product was purified by semi-preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected terasaccharide 9 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected tetrasaccharide 9 (2.0 mg, 2.72 µmol, 17% over 11 steps, 
based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.15 (d, J = 1.4 Hz, 1H), 4.77 (d, J = 7.7 Hz, 1H), 4.70 (d, J = 7.6 Hz, 1H), 
4.54 (d, J = 8.0 Hz, 1H), 4.29 (dd, J = 12.5, 3.2 Hz, 2H), 4.16 (dd, J = 3.4, 1.7 Hz, 1H), 4.13 (td, J = 6.0, 
3.3 Hz, 1H), 4.07 – 4.00 (m, 3H), 3.99 – 3.95 (m, 2H), 3.94 – 3.83 (m, 9H), 3.82 – 3.73 (m, 6H), 3.70 
(dd, J = 9.9, 7.7 Hz, 1H), 3.13 – 3.07 (m, 2H), 1.82 – 1.73 (m, 4H), 1.55 (dt, J = 15.4, 7.6 Hz, 2H) ppm. 
13C NMR{1H} (151 MHz, D2O) δ = 106.9, 103.3, 102.9, 101.4, 82.9, 81.6, 81.0, 80.1, 75.5, 74.1, 73.8, 
72.3, 71.5, 70.0, 69.1, 68.9, 68.8, 67.6, 67.5, 67.5, 66.4, 60.2, 60.0, 60.0, 38.4, 27.2, 25.4, 21.1 ppm. 
HRMS: m/z [M+H]+ calcd. for C28H51NO20: 722.3082, found: 722.3042. 
RP-HPLC of the deprotected tetrasaccharide 9 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1 % 




1H NMR (600 MHz, D2O) of tetrasaccharide 9: 
 
13C NMR (151 MHz, D2O) of tetrasaccharide 9: 
 









Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected tetrasaccharide 10. The crude product was purified by normal phase HPLC using a 




Crude NP-HPLC of protected tetrasaccharide 10 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 




The protected tetrasaccharide 10 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was added. 
The solution was stirred overnight at rt. The reaction mixture was neutralized using prewashed 
Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. The semi-




Crude RP-HPLC of semi-protected tetrasaccharide 10 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected tetrasaccharide 10 (2.0 mg, 2.77 µmol, 16% over 11 
steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 5.39 (s, 1H), 4.70 (d, J = 7.8 Hz, 1H), 4.62 (d, J = 7.9 Hz, 1H), 4.59 (d, J = 
7.8 Hz, 1H), 4.38 – 4.37 (m, 1H), 4.32 (d, J = 2.3 Hz, 1H), 4.31 – 4.28 (m, 1H), 4.24 – 4.19 (m, 2H), 4.15 
– 4.05 (m, 8H), 4.00 (d, J = 12.5 Hz, 1H), 3.98 – 3.80 (m, 9H), 3.72 – 3.66 (m, 2H), 3.18 (t, J = 7.4 Hz, 
2H), 1.90 – 1.82 (m, 4H), 1.66 – 1.60 (m, 2H) ppm. 13C NMR{1H} (176 MHz, D2O) δ = 107.0, 101.1, 
100.8, 100.4, 81.6, 79.0, 77.9, 74.3, 72.9, 71.5, 71.3, 70.4, 70.4, 68.5, 68.4, 67.9, 67.5, 67.0, 66.8, 
66.4, 66.4, 66.2, 58.9, 58.7, 37.1, 25.9, 24.2, 19.8 ppm. HRMS: m/z [M+Na]+ calcd. for C28H51NO20: 
744.2902, found: 744.2903. 
RP-HPLC of deprotected tetrasaccharide 10 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 





1H NMR (700 MHz, D2O) of tetrasaccharide 10:  
 
13C NMR (176 MHz, D2O) of tetrasaccharide 10:  
 









Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected tetrasaccharide 11. The crude product was purified by normal phase HPLC using a 




Crude NP-HPLC of protected tetrasaccharide 11 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The Tetrasaccharide 11 was dissolved in 5 mL THF and 1 mL of 0.5 M NaOMe was added. The solution 
was stirred overnight at rt. The reaction mixture was neutralized using prewashed Amberlite IR-120 
resin, the resin was filtered off and the solvent was removed in vacuo. The semi-protected product 




Crude RP-HPLC of semi-protected terasaccharide 11 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected tetrasaccharide 11 (1.2 mg, 1.66 µmol, 10% over 11 
steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.40 (d, J = 1.3 Hz, 1H), 4.62 (d, J = 8.0 Hz, 1H), 4.60 (d, J = 7.9 Hz, 1H), 
4.40 – 4.37 (m, 2H), 4.30 (ddd, J = 12.3, 6.1, 3.0 Hz, 2H), 4.20 (dd, J = 10.3, 3.0 Hz, 1H), 4.15 – 4.03 (m, 
5H), 4.02 – 3.97 (m, 3H), 3.96 – 3.83 (m, 11H), 3.83 – 3.79 (m, 1H), 3.69 (dd, J = 9.9, 7.9 Hz, 1H), 3.20 
– 3.16 (m, 2H), 1.86 (tt, J = 14.2, 7.1 Hz, 4H), 1.67 – 1.60 (m, 2H) ppm. 13C NMR{1H} (151 MHz, D2O) 
δ = 107.0, 101.7, 101.2, 100.1, 81.6, 80.1, 79.0, 77.6, 74.3, 72.9, 72.5, 71.2, 70.5, 68.5, 67.9, 67.7, 
67.6, 66.9, 66.3, 66.2, 66.2, 58.9, 58.7, 58.7, 37.1, 25.9, 24.1, 19.8 ppm. HRMS: m/z [M+H]+ calcd. for 
C28H51NO20: 722.3082, found: 722.3125. 
RP-HPLC of deprotected tetrasaccharide 11 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 




1H NMR (600 MHz, D2O) of tetrasaccharide 11: 
 
13C NMR (151 MHz, D2O) of tetrasaccharide 11: 
 









Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected pentasaccharide 12. The crude product was purified by normal phase HPLC using a 




Crude NP-HPLC of protected pentasaccharide 12 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected branched pentasaccharide 12 was dissolved in 5 mL THF and 0.5 mL of 0.5 M NaOMe 
was added. The solution was stirred overnight at rt. The reaction mixture was neutralized using 
prewashed Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. 




Crude RP-HPLC of semi-protected pentasaccharide 12 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected pentasaccharide 12 (2.7 mg, 3.05 µmol, 16% over 14 
steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.40 (s, 1H), 4.85 (d, J = 7.7 Hz, 1H), 4.78 (d, J = 7.6 Hz, 1H), 4.65 (d, J = 
7.9 Hz, 1H), 4.62 (d, J = 8.0 Hz, 1H), 4.42 – 4.37 (m, 3H), 4.31 – 4.25 (m, 2H), 4.21 (q, J = 8.7 Hz, 1H), 
4.14 – 4.04 (m, 6H), 4.03 – 3.76 (m, 24H), 3.18 (t, J = 7.4 Hz, 2H), 1.90 – 1.81 (m, 4H), 1.63 (dt, J = 
15.0, 7.7 Hz, 2H) ppm. 13C NMR{1H} (151 MHz, D2O) δ = 106.9, 102.1, 101.6, 101.0, 100.1, 81.6, 80.1, 
79.7, 79.0, 78.0, 74.2, 72.8, 72.7, 72.5, 71.1, 70.3, 68.7, 67.9, 67.7, 67.6, 67.0, 66.3, 66.2, 66.2, 66.1, 
58.9, 58.7, 58.7, 37.1, 25.9, 24.1, 19.8 ppm. HRMS: m/z [M+H]+ calcd. for C34H61NO25: 884.3610, 
found: 884.3550. 
RP-HPLC of deprotected pentasaccharide 12 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 





1H NMR (600 MHz, D2O) of pentasaccharide 12: 
 
13C NMR (151 MHz, D2O) of pentasaccharide 12: 
 










Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
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Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected hexasaccharide 13. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected hexasaccharide 13 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in ethyl acetate 





The protected hexasaccharide 13 was dissolved in 5 mL THF and 0.5 mL of 0.5 M NaOMe was added. 
The solution was stirred overnight at rt. The reaction mixture was neutralized using prewashed 
Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. The semi-




Crude RP-HPLC of semi-protected hexasaccharide 13 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected hexasaccharide 13 (1.9 mg, 1.82 µmol, 11% over 17 
steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.33 (s, 1H), 4.79 (d, J = 7.8 Hz, 1H), 4.72 (d, J = 7.6 Hz, 1H), 4.60 (d, J = 
7.9 Hz, 1H), 4.56 – 4.54 (m, 2H), 4.35 – 4.30 (m, 3H), 4.24 – 4.21 (m, 2H), 4.15 – 4.09 (m, 2H), 4.07 – 
3.99 (m, 8H), 3.96 (dd, J = 9.9, 3.1 Hz, 1H), 3.94 – 3.90 (m, 2H), 3.90 – 3.84 (m, 7H), 3.84 – 3.69 (m, 
11H), 3.63 (dd, J = 9.7, 8.0 Hz, 1H), 3.11 (t, J = 7.4 Hz, 2H), 1.83 – 1.75 (m, 4H), 1.59 – 1.53 (m, 2H) 
ppm.13C NMR{1H} (151 MHz, D2O) δ = 108.0, 103.1, 102.7, 102.3, 102.1, 101.2, 82.7, 81.3, 80.8, 80.1, 
79.0, 75.3, 74.0, 73.9, 73.6, 72.3, 72.0, 71.6, 71.4, 69.8, 69.6, 69.0, 68.8, 68.7, 68.7, 68.3, 68.0, 67.4, 
67.4, 67.3, 67.3, 67.2, 60.0, 59.9, 59.8, 59.8, 38.2, 27.0, 25.2, 20.9 ppm. HRMS: m/z [M+Na]+ calcd. for 
C40H71NO30: 1068.3958, found: 1068.4056. 
RP-HPLC of deprotected hexaasaccharide 13 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 





1H NMR (600 MHz, D2O) of hexasaccharide 13: 
 
13C NMR (151 MHz, D2O) of hexasaccharide 13: 
 










Linker functionalized resin L (53 mg, 16.9 µmol) was placed in the reaction vessel of the synthesizer 
and synthesizer modules were applied as follows: 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB2, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
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Module D (2 x 3.75 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor afforded 
the protected heptasaccharide 14. The crude product was purified by normal phase HPLC using a 
preparative YMC Diol column. 
Crude NP-HPLC of protected heptasaccharide 14 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 







The protected heptasaccharide 14 was dissolved in 5 mL THF and 0.5 mL of 0.5 M NaOMe was added. 
The solution was stirred overnight at rt. The reaction mixture was neutralized using prewashed 
Amberlite IR-120 resin, the resin was filtered off and the solvent was removed in vacuo. The semi-
protected product was purified by semi-preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected heptasaccharide 14 (ELSD trace): 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 0.1% of formic 
acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EE/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and the resulting 
solution was added to a round-bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was 
flushed with Ar for 10 min then saturated with H2 for 10 min and stirred under a H2-atmosphere 
overnight. After filtration of the reaction mixture through a syringe filter the solvents were 
evaporated to provide the fully deprotected heptasaccharide 14 (1.9 mg, 1.55  µmol, 9% over 21 
steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.40 (d, J = 0.8 Hz, 1H), 4.86 (d, J = 7.7 Hz, 1H), 4.78 (d, J = 7.6 Hz, 1H), 
4.69 (d, J = 7.9 Hz, 1H), 4.62 (dd, J = 7.9, 4.6 Hz, 3H), 4.41 (dd, J = 8.1, 3.2 Hz, 2H), 4.38 (dd, J = 3.4, 1.5 
Hz, 1H), 4.32 – 4.28 (m, 2H), 4.23 – 4.18 (m, 3H), 4.14 – 4.05 (m, 11H), 4.03 (dd, J = 9.9, 3.2 Hz, 1H), 
4.01 – 3.97 (m, 2H), 3.96 – 3.90 (m, 7H), 3.90 – 3.80 (m, 11H), 3.78 (dd, J = 9.8, 7.7 Hz, 1H), 3.72 – 
3.66 (m, 2H), 3.20 – 3.16 (m, 2H), 1.90 – 1.82 (m, 4H), 1.63 (dt, J = 15.3, 7.7 Hz, 2H) ppm. 13C NMR{1H} 
(151 MHz, D2O) δ = 107.0, 102.1, 101.6, 101.2, 101.2, 100.9, 100.1, 81.6, 80.3, 79.7, 79.1, 77.9, 74.4, 
72.9, 72.9, 72.6, 71.4, 71.4, 71.0, 70.5, 70.4, 70.3, 68.8, 68.5, 68.5, 68.0, 67.7, 67.6, 67.3, 67.2, 67.2, 
66.9, 66.4, 66.4, 66.2, 66.2, 66.1, 59.0, 58.8, 58.8, 58.7, 37.1, 25.9, 24.2, 19.9 ppm. HRMS: m/z 
[M+Na]+ calcd. for C46H81NNaO35: 1230.4486, found: 1230.4396. 
RP-HPLC of deprotected heptasaccharide 14 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O (containing 0.1% 
of formic acid) in MeCN (45 min, flow rate 0.7 mL/min). 
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1H NMR (600 MHz, D2O) of heptasaccharide 14: 
 
13C NMR (151 MHz, D2O) of heptasaccharide 14: 
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